Glaxosmithkline



Ebitda Changement Date
AbbVie USD 6.92B 258M 2024-12
Amgen USD 3.71B 265M 2024-12
AstraZeneca USD 5.26B 597M 2024-12
Aurora Cannabis CAD -25369000 7.78M 2024-12
Bausch Health Companies USD 851M 135M 2024-09
Bristol-Myers Squibb USD 4.91B 445M 2024-12
Canopy Growth CAD -8628000 2.1M 2024-12
Corcept Therapeutics USD 25.54M 21.37M 2024-12
Drreddys Laboratories INR 23.31B 1.4B 2024-12
Eli Lilly USD 6.17B 1.27B 2024-12
GlaxoSmithKline GBP 2.08B 1.22B 2024-12
Glaxosmithkline GBP 1.69B 1.6B 2024-12
Indivior 9M 92M 2024-09
J&J USD 6.12B 1.51B 2024-12
Merck USD 7.12B 1.06B 2024-12
Novartis USD 5.19B 319M 2024-12
Pacira USD 50.78M 8.5M 2024-12
Perrigo USD 245.1M 49.4M 2024-12
Pfizer USD 4.71B 3.04B 2024-12
Prestige Brands USD 98.83M 6.56M 2024-12
Roche Holding CHF 12.68B 2.36B 2024-06
Sanofi EUR 4.25B 2.22B 2024-09
Supernus Pharmaceuticals USD 49.15M 11.8M 2024-12
Takeda JPY 254.6B 125.66B 2024-12
Teva Pharmaceutical Industries USD 261M 1.01B 2024-12
Zoetis USD 894M 145M 2024-12



Glaxosmithkline - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2025.